---
title: "Veradermics, Incorporated (MANE) Gets a Buy from LifeSci Capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292791552.md"
description: "LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Veradermics (MANE) with a $170 price target. Additionally, B. Riley Securities initiated coverage with a Buy rating and the same $170 target. The report highlights Katkhuda's strong track record as a 5-star analyst in the healthcare sector."
datetime: "2026-07-15T14:35:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292791552.md)
  - [en](https://longbridge.com/en/news/292791552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292791552.md)
generator: "portal-rs"
---

# Veradermics, Incorporated (MANE) Gets a Buy from LifeSci Capital

In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Veradermics, Incorporated, with a price target of $170.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Katkhuda is a 5-star analyst with an average return of 32.4% and a 58.62% success rate. Katkhuda covers the Healthcare sector, focusing on stocks such as Disc Medicine, MoonLake Immunotherapeutics, and Eledon Pharmaceuticals.

In a report released today, B. Riley Securities also initiated coverage with a Buy rating on the stock with a $170.00 price target.

### Related Stocks

- [MANE.US](https://longbridge.com/en/quote/MANE.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [MLTX.US](https://longbridge.com/en/quote/MLTX.US.md)
- [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md)
- [RILY.US](https://longbridge.com/en/quote/RILY.US.md)
- [RILYL.US](https://longbridge.com/en/quote/RILYL.US.md)
- [RILYG.US](https://longbridge.com/en/quote/RILYG.US.md)
- [RILYN.US](https://longbridge.com/en/quote/RILYN.US.md)
- [RILYK.US](https://longbridge.com/en/quote/RILYK.US.md)
- [RILYP.US](https://longbridge.com/en/quote/RILYP.US.md)
- [RILYZ.US](https://longbridge.com/en/quote/RILYZ.US.md)
- [RILYT.US](https://longbridge.com/en/quote/RILYT.US.md)

## Related News & Research

- [Bamco Inc. NY Purchases 169,913 Shares of Veradermics, Incorporated $MANE](https://longbridge.com/en/news/297140282.md)
- [Veradermics, Incorporated (MANE) Receives a Buy from Jefferies](https://longbridge.com/en/news/286447750.md)
- [Morgans Remains a Buy on EchoIQ Limited (EIQ)](https://longbridge.com/en/news/297720502.md)
- [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md)
- [RBC Capital Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)](https://longbridge.com/en/news/297724530.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**